(Reuters) - The U.S. Food and Drug Administration on Thursday approved a new drug for advanced colon cancer developed by Bayer AG, a month ahead of the agency's expected action date for a decision. The drug, to be sold under the brand name Stivarga, was approved to treat colon cancer that has progressed after prior treatment or that has spread to other parts of the body, the agency said. "Someone has clearly lit a fire under the FDA," Sanford Bernstein analyst Geoffrey Porges said of the speedy approval. ...
Source: http://news.yahoo.com/novo-nordisk-says-diabetes-drug-approved-japan-052511113--finance.html
cbi the shins atomic clock daylight savings time john mccain game changer selection sunday
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন